Introduction: Diabetes Mellitus (DM) is a risk factor for reduced bone mass. Several bone metabolic pathways seem to be disrupted in patients with type 1 diabetes mellitus (T1DM). Materials and Methods: We evaluated 40 children and adolescents with T1DM (mean±SD age 13.04±3.53 years, mean±SD T1DM duration 5.15±3.33years) and 40 healthy age-and gendermatched controls (mean±SD age 12.99±3.3years). Osteoprotegerin (OPG), Receptor Activator of Nuclear factor-KappaB Ligand(s-RANKL), Osteocalcin, C-telopeptide crosslinks-CTX, electrolytes, PTH, total 25(OH)D were measured and total body Bone Mineral Density(BMD) was evaluated with dual energy X-ray absorptiometry (DXA).
.) Bone formation was not significantly affected. 
